secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2026-08-05T12:30:20+00:00
Accession:  0001493152-26-036109
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata announces Aug 25 launch of Tome Foundational Treatment at $178 per set
------------------------------------------------------------------------------

- First commercial product Tome Foundational Treatment launches August 25, 2026; waitlist gets early preorder access.
- Four once-weekly treatments per set, priced at $178 (approx $45/treatment), sold exclusively at tomeskincare.com.
- Company shifts to commercialize skincare products, reducing regulatory burdens and expanding consumer market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/0001493152-26-036109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer